BIMIZCI Crosses 500,000 Share Threshold; Nominates Three Directors at Medallion Financial; Cites Deteriorating Performance, and Federal Securities Fraud Judgment
BIMIZCI has launched the “Restore the Shine” campaign (www.restoretheshine.com) to replace 3 directors at Medallion Financial We are asking stockholders... Read more.
Mattel is Searching for the First Hot Wheels Tiniest Team Principal
Entries to be judged by some of the biggest names in the automotive industry: Formula 1® President and CEO Stefano Domenicali, FIA Formula One World Drivers’... Read more.
FUJIFILM Cellular Dynamics Launches New iPSC Manufacturing Facility in Madison
Site will serve as company’s new headquarters and expands capacity and capabilities for induced pluripotent stem cell development and manufacturing New facility... Read more.
Securities Fraud Investigation Into Armstrong World Industries, Inc. (AWI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Armstrong World Industries, Inc. (“Armstrong World” or... Read more.
BMI Investigation Notice: BFA Announces Badger Meter Investigation on behalf of Investors after Demand Issues Disclosed – Contact the Firm if You Lost Money
BFA Law is investigating whether Badger Meter committed securities fraud relating to its representations about demand for the company’s products and its prospects... Read more.
Illumia Names Laura Newell-McLaughlin Chief Operating Officer
Longtime company leader will oversee operational unification and advance Illumia’s AI transformation priorities SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#HigherEd—Illumia,... Read more.
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
— Data Were Presented at the American Thoracic Society (ATS) International Conference 2026 — — All Patients Receive Molgramostim During the OL... Read more.
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
— Data Were Presented at the American Thoracic Society (ATS) International Conference 2026 — — All Patients Receive Molgramostim During the OL... Read more.
Babcock & Wilcox Enterprises Announces Closing of Common Stock Offering
AKRON, Ohio–(BUSINESS WIRE)–$BW–Babcock & Wilcox Enterprises, Inc. (“B&W” or the “Company”) (NYSE: BW) announced today the closing... Read more.
Babcock & Wilcox Enterprises Announces Closing of Common Stock Offering
AKRON, Ohio–(BUSINESS WIRE)–$BW–Babcock & Wilcox Enterprises, Inc. (“B&W” or the “Company”) (NYSE: BW) announced today the closing... Read more.